Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 350 of 508 publications.

Poulos C. A review of discrete choice experiment studies of preferences for vaccine features. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 24, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A220.

Gray E, Eden M, Vass C, McAllister M, Louviere J, Payne K. Valuing preferences for the process and outcomes of clinical genetics services: a pilot study. Patient. 2016 Apr;9(2):135-47. doi: 10.1007/s40271-015-0133-0

Poulos C, Kinter E, Yang J-C, Bridges JFP, Posner JD, Reder AT. Patient preferences for injectable treatments for multiple sclerosis in the United States: a discrete-choice experiment. Patient. 2016 Apr;9(2):171-80. doi: 10.1007/s40271-015-0136-x

Mansfield C, Thomas N, Gebben D, Lucas M. Preferences for multiple sclerosis treatments: differences across subgroups of US patients with RRMS. Poster presented at the 68th American Academy of Neurology Annual Meeting; April 2016. Vancouver, Canada.

Mansfield C, Thomas N, Gebben D, Lucas M, Hauber B. Differences in preferences for disease-modifying treatments across subgroups of U.S. patients with relapsing multiple sclerosis. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 19, 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S66.

Porteous T, Ryan M, Bond C, Watson M, Watson V. Managing minor ailments; the public's preferences for attributes of community pharmacies. A discrete choice experiment. PLoS One. 2016 Mar 31;11(3):e0152257. doi: 10.1371/journal.pone.0152257

Poulos C, Kinter E, Yang JC, Bridges JF, Posner J, Gleibner E, Muhlbacher A, Kieseier B. A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany. Ther Adv Neurol Disord. 2016 Mar;9(2):95-104. doi: 10.1177/1756285615622736.

Mansfield C, Tangka FKL, Ekwueme DU, Smith JL, Guy GP, Li C, Hauber AB. Stated preference for cancer screening: a systematic review of the literature, 1990–2013. Prev Chronic Dis. 2016 Feb 25;13:E27. doi: 10.5888/pcd13.150433

Cleland J, Johnston P, Watson V, Krucien N, Skatun D. What do UK doctors in training value in a post? A discrete choice experiment. Med Educ. 2016 Feb;50(2):189-202. doi: 10.1111/medu.12896

Dickey H, Ikenwilo D, Norwood P, Watson V, Zangelidis A. "Doctor my eyes": a natural experiment on the demand for eye care services. Soc Sci Med. 2016 Feb;150:117-27. doi: 10.1016/j.socscimed.2015.12.037

Wald JS, Vishwanath NS, Shrestha M, Poulos C, Simon L, Vijayakumar G. Supporting diabetes medication understanding and adherence through a health literacy intervention, Meducation, in Kerala, India. In: LaBresh K, editors. Improving outcomes for noncommunicable diseases in low- and middle-income countries. Publication No. Bk-0017-1608 ed. Research Triangle Park: NC. RTI Press Publication; 2016. p.61-78. doi: 10.3768/rtipress.2016.bk.0017.1608

Cooley P, Rogers SM, Poulos C, Scruggs MD, Rineer JI, Wheaton WD, Allaire BT, Wagener DK. Microsimulation models to assess impact of health programs to address obesity and low birth weight in Indonesia. In: K. LaBresh, editors. Improving outcomes for noncommunicable diseases in low- and middle-income countries. Publication No. Bk-0017-1608 ed. Research Triangle Park: NC. RTI Press Publication; 2016. p.35-60. doi: 10.3768/rtipress.2016.bk.0017.1608

Liede A, Fairchild A, Friedman S, Amelio J, Hallett DC, Mansfield CA, Metcalfe KA. Risk-reducing surgery and cancer-related distress among female BRCA1 and BRCA2 mutation carriers. Poster presented at the 2015 San Antonio Breast Cancer Symposium; December 8, 2015. San Antonio, TX.

Poulos C, Kinter E, Posner J, van Beek J. A comparison of stated preferences for injectable disease-modifying treatments for multiple sclerosis: compliant vs. non-compliant patients. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Mansfield CA, Thomas N, Gebben D, Lucas M. US RRMS patient preferences for multiple sclerosis treatments: an online survey. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Mansfield CA, Sikirica M, Pugh A, Poulos C, Martin AA, Ruiz Moran L, Morano Larragueta R. Patient preferences for attributes of type 2 diabetes mellitus (T2DM) treatments in Spain. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Vass C, Rigby D, Campbell S, Payne K. Investigating the framing-effects of risk attributes in a discrete choice experiment for a national breast screening programme. Presented at the 37th Annual Meeting of the Society for Medical Decision Making (SMDM); October 19, 2015. St. Louis, MO.

Vass C, Rigby D, Campbell S, Tate K, Stewart A, Payne K. Using eye-tracking methods to investigate the framing of risk attributes in discrete choice experiments. Poster presented at the 37th Annual Meeting of the Society for Medical Decision Making (SMDM); October 18, 2015. St. Louis, MO.

Dickinson KL, Patil SR, Pattanayak SK, Poulos C, Yang JH. Nature's call: impacts of sanitation choices in Orissa, India. Econ Dev Cult Change. 2015 Oct;64(1):1-29.

Hauber AB, Gilsenan A, Juhaeri J, Zhong Y, Noel B. Benefit risk assessment: understanding and using patient preference methodologies. Presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.

Liu X, Sarr M, Swanson T. Resistance to the regulation of common water resources in rural Tunisia. Land Econ. 2015 Aug;91:435-59. doi: 10.3368/le.91.3.435

McAteer A, Yi D, Watson V, Norwood P, Ryan M, Hannaford PC, Elliott AM. Exploring preferences for symptom management in primary care: a discrete choice experiment using a questionnaire survey. Br J Gen Pract. 2015 Jul;65(636):e478-88. doi: 10.3399/bjgp15X685705

Kinter E, van Beek J, Christensen K, Poulos C, Posner J, Sabatella G. Preferences of patients with multiple sclerosis for attributes of injectable MS treatments in the United Kingdom and France. Poster presented at the 1st Congress of the European Academy of Neurology; June 20, 2015. Berlin, Germany.

Mansfield C, Viswanathan M, Woodell C, Ohadike YU, Kennedy Lesch LJ, Malveaux FJ. Improving asthma outcomes for children: many paths to progress. Pediatr Allergy Immunol Pulmonol. 2015 Jun;28(2):80-6. doi: 10.1089/ped.2014.0440

Poulos C, Posner J, Hauber AB, Kauf TK, Potashman M, Viscusi ER, Aeder M. Patient preferences for outcomes following abdominal surgery: gI symptom tolerance. Poster presented at the American Society of Colon and Rectal Surgeons 2015 Annual Scientific Meeting; May 2015. Boston, MA.

Mansfield CA, Poulos C, Hackshaw MD, Pugh AL, Jobanputra M. Patient preferences for first-line maintenance treatments for ovarian cancer. Presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.

Smith VK, Mansfield CA. The design of benefit cost “architecture” for homeland security policy analysis. In: Mansfield C, Smith VK, editors. Benefit-cost analyses for security policies: does increased safety have to reduce efficiency? Cheltenhen: United Kingdom. Edward Elgar Publishing; 2015.

Mansfield CA, Smith VK. Introducing the issues: Meeting the challenges in evaluating homeland security policy. In: Mansfield C, Smith VK, editors. Benefit-cost analyses for security policies: does increased safety have to reduce efficiency? Cheltenhen: United Kingdom. Edward Elgar Publishing; 2015.

Mansfield CA, Smith VK. What we know and what we need to learn. In: Mansfield C, Smith VK, editors. Benefit-cost analyses for security policies: does increased safety have to reduce efficiency? Cheltenhen: United Kingdom. Edward Elgar Publishing; 2015.

Kenter JO, O'Brien L, Hockley N, Ravenscroft N, Fazey I, Irvine KN, Reed MS, Christie M, Brady E, Bryce R, Church A, Cooper N, Davies A, Evely A, Everard M, Fish R, Fisher JA, Jobstvogt N, Molloy C, Orchard-Webb J, Ranger S, Ryan M, Watson V, Williams S. What are shared and social values of ecosystems? Ecol Econ. 2015 Mar;111:86-99. doi: 10.1016/j.ecolecon.2015.01.006

Srinivas S, Mansfield CA, Sandin R, Hauber AB, Hariharan S, Matczak EM, Pugh AL, Chen C. Exploring the effect of medication features in renal cell carcinoma: a patient preference study. Poster presented at the 2015 Genitourinary Cancers Symposium; February 2015.

Poulos C, Johnson FR, Krishnarajah F, Anonychuk A, Misurski D. Pediatricians' preferences for infant meningococcal vaccination. Value Health. 2015 Jan;18(1):67-77. doi: 10.1016/j.jval.2014.10.010

Mansfield CA, Smith VK. Benefit–cost analyses for security policies. Cheltenham: United Kingdom. Edward Elgar Publishing; 2015.

Jobstvogt N, Watson V, Kenter JO. Looking below the surface: the cultural ecosystem service values of UK marine protected areas (MPAs). Ecosyst Serv. 2014 Dec;10:97-110. doi: 10.1016/j.ecoser.2014.09.006

Vass CM, Rigby D, Campbell S, Tate K, Stewart A, Payne K. Using eye-tracking to explore the framing of risk attributes in a discrete choice experiment. Presented at the International Academy of Health Preference Researchers 1st Annual Meeting; November 8, 2014. Amsterdam, The Netherlands. Previously presented at the Health Economists’ Study Group winter Meeting.

Gonzalez JM, Poulos C, Mollon P. Understanding medication adherence using stated-preference data. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.

Hauber AB, Standaert B, Poulos C. Development of a survey to quantify parents' priorities for vaccinating children against rotavirus. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands.

Vass CM, Rigby D, Campbell S, Payne K. Investigating the framing-effects of risk attributes in discrete choice experiments: a pilot study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. [abstract] Value Health. 2014 Nov; 17(7):A648. doi: 10.1016/j.jval.2014.08.2349

Vass C, Rigby D, Campbell S, Tate K, Stewart A, Payne K. Investigating the framing of risk attributes in a discrete choice experiment: an application of eye-tracking and think aloud. Poster presented at the 36th Annual Meeting of the Society for Medical Decision Making (SMDM); October 20, 2014. Miami, FL.

Poulos C, Hauber AB, González JM, Turpcu A. Patients' willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken). 2014 Jul;66(7):1008-15. doi: 10.1002/acr.22265

Luchini S, Watson V. Are choice experiments reliable? Evidence from the lab. Econ Lett. 2014 Jul;124(1):9-13. doi: 10.1016/j.econlet.2014.04.005

Regier DA, Watson V, Burnett H, Ungar WJ. Task complexity and response certainty in discrete choice experiments: an application to drug treatments for juvenile idiopathic arthritis. J Behav Exp Econ. 2014 Jun;50:40-9. doi: 10.1016/j.socec.2014.02.009

Harrison M, Rigby D, Vass C, Flynn T, Louviere J, Payne K. Risk as an attribute in discrete choice experiments: a systematic review of the literature. Patient. 2014 Jun;7(2):151-70. doi: 10.1007/s40271-014-0048-1

Poulos C, Kinter E, Yang JC, Bridges JFP, Posner JD, Reder A. United States multiple sclerosis patients' preferences for injectable treatments. Poster presented at the European Federation of Neurological Sciences - European Neurological Society Joint Congress of European Neurology; May 31, 2014.

Hauber AB, Nguyen H, Posner JD, Ervin CM, LaRue S, Kalsekar I. Patient preferences for frequency of glucagon-like peptide-1 receptor agonist (glp-1ra) injections in the treatment of type 2 diabetes. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014. [abstract] Value Health. 2014 May; 17(3):A255.

Van Houtven G, Mansfield C, Phaneuf DJ, von Haefen R, Milstead B, Kenney MA, Reckhow KH. Combining expert elicitation and stated-preference methods to value ecosystem services from improved lake water quality. Ecol Econ. 2014 Mar;99:40-52. doi: 10.1016/j.ecolecon.2013.12.018.

Hiligsmann M, Dellaert BG, Dirksen CD, van der Weijden T, Goemaere S, Reginster JY, Watson V, Boonen A. Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment. Arthritis Res Ther. 2014 Jan 31;16(1):R36. doi: 10.1186/ar4465

Smith VK, Mansfield C, Strong A. How should the health benefits of food safety programs be measured? In: Bolin K, Blomquist GC, editors. Advances in health economics and health services research. Somerville: MA. Emerald Group Publishing Limited; 2014. p.161-202.

Gray E, Eden M, Vass CM, McAllister M, Louviere J, Payne K. Valuing preferences for the process and outcomes of clinical genetics services: a pilot study. Poster presented at the Health Economists’ Study Group Winter Meeting; 2014. Sheffield, United Kingdom.

Brown DS, Poulos C, Johnson FR, Chamiec-Case L, Messonnier ML. Adolescent girls' preferences for HPV vaccines: A discrete choice experiment. In: Glenn C. Blomquist, Kristian Bolin (ed.), editors. Preference measurement in health. Bingley: United Kingdom. Emerald Group Publishing Limited; 2014. p.93-121. doi: 10.1108/S0731-2199_2014_0000024002